{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:41Z","timestamp":1793442701151,"version":"4.5.0"},"reference-count":296,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2026ZD01910002"],"award-info":[{"award-number":["2026ZD01910002"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82522095"],"award-info":[{"award-number":["82522095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2023E005TS01"],"award-info":[{"award-number":["CI2023E005TS01"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2026A05002"],"award-info":[{"award-number":["CI2026A05002"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2026A00612"],"award-info":[{"award-number":["CI2026A00612"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2025D002"],"award-info":[{"award-number":["CI2025D002"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115380","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:28:05Z","timestamp":1789774085000},"page":"115380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Postoperative glioblastoma management: from relapse mechanisms and clinical interventions to emerging drug delivery strategies"],"prefix":"10.1016","volume":"399","author":[{"given":"Wenping","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huarong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb0005","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1097\/JS9.0000000000002634","article-title":"Comprehensive multi-omics approach reveals critical genes and immunometabolic networks in glioblastoma","volume":"111","author":"Yi","year":"2025","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","article-title":"Brain immunology and immunotherapy in brain tumours","volume":"20","author":"Sampson","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115380_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2026.115380_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217601","article-title":"Advancing glioblastoma therapy: learning from the past and innovations for the future","volume":"617","author":"Rana","year":"2025","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41571-025-01020-2","article-title":"Targeting the glioblastoma resection margin with locoregional nanotechnologies","volume":"22","author":"Kisby","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nec.2024.08.007","article-title":"Supramarginal resection of glioblastoma: a review[J]","volume":"36","author":"Goethe","year":"2024","journal-title":"Neurosurg. Clin. N. Am."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb0040","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a society for neuro-oncology (SNO) and European Society of Neuro-oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0045","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","article-title":"Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma","volume":"28","author":"Qazi","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2026.115380_bb0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.wneu.2017.04.053","article-title":"Recurrence pattern analysis of primary glioblastoma","volume":"103","author":"Rapp","year":"2017","journal-title":"World Neurosurg."},{"issue":"860","key":"10.1016\/j.jconrel.2026.115380_bb0055","doi-asserted-by":"crossref","first-page":"eadv8761","DOI":"10.1126\/scitranslmed.adv8761","article-title":"Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing postoperative blood-brain barrier disruption","volume":"18","author":"Fernandes","year":"2026","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0060","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/brainsci12070893","article-title":"The dynamics of tumor-infiltrating myeloid cell activation and the cytokine expression profile in a glioma resection site during the post-surgical period in mice","volume":"12","author":"Ortiz-Rivera","year":"2022","journal-title":"Brain Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0065","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb0070","article-title":"Single-cell transcriptomic analysis of glioblastoma reveals pericytes contributing to the blood-brain-tumor barrier and tumor progression","volume":"5","author":"Li","year":"2024","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.jconrel.2026.115380_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106510","article-title":"CRISPR\/Cas9-induced knockout reveals the role of ABCB1 in the response to temozolomide, carmustine and lomustine in glioblastoma multiforme","volume":"185","author":"Radtke","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"18","key":"10.1016\/j.jconrel.2026.115380_bb0080","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/j.neuron.2024.07.026","article-title":"Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier","volume":"112","author":"Xie","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s13046-024-03231-4","article-title":"Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment","volume":"43","author":"Bastiancich","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"30","key":"10.1016\/j.jconrel.2026.115380_bb0090","doi-asserted-by":"crossref","first-page":"eadw8330","DOI":"10.1126\/sciadv.adw8330","article-title":"Construction of a whole-brain panorama for glioma vasculature reveals tumor heterogeneity and blood-brain barrier disruption","volume":"11","author":"Huang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115380_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123730","article-title":"Dual-responsive nanoparticle system for enhanced blood-brain barrier crossing and glioblastoma penetration","volume":"327","author":"Zheng","year":"2026","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41467-023-35957-8","article-title":"Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/neuonc\/5.2.79","article-title":"A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma","volume":"5","author":"Westphal","year":"2003","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0110","first-page":"vdz013","article-title":"Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects","volume":"1","author":"Hafeez","year":"2019","journal-title":"Neurooncol. Adv."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb0115","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1200\/JCO.1998.16.6.2202","article-title":"Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results","volume":"16","author":"Bigner","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.jconrel.2026.115380_bb0120","doi-asserted-by":"crossref","first-page":"27623","DOI":"10.1021\/acsami.2c05147","article-title":"Multifunctional hybrid hydrogel system enhanced the therapeutic efficacy of treatments for postoperative glioma","volume":"14","author":"Cao","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0125","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1038\/s41467-024-48606-5","article-title":"Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012934","article-title":"Neural stem cell-delivered oncolytic virus via intracerebroventricular administration enhances glioblastoma therapy and immune modulation","volume":"13","author":"Chai","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"50","key":"10.1016\/j.jconrel.2026.115380_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202406036","article-title":"Postoperative injection of a triptolide-preloaded hydrogel prevents the recurrence of glioblastoma by dual-pathway activation of ferroptosis","volume":"20","author":"Wu","year":"2024","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb0140","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ymthe.2020.02.008","article-title":"Developing implantable scaffolds to enhance neural stem cell therapy for post-operative glioblastoma","volume":"28","author":"Sheets","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115380_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114225","article-title":"Biodegradable nanofibrous scaffolds enhance standard of care for glioblastoma via localized targeted therapy","volume":"387","author":"Woodring","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115380_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115820","article-title":"Glioblastoma cell adhesion properties through bacterial cellulose nanocrystals in polycaprolactone\/gelatin electrospun nanofibers","volume":"233","author":"Unal","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2026.115380_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124710","article-title":"3D-printed implants loaded with acriflavine for glioblastoma treatment","volume":"665","author":"Korelidou","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"40","key":"10.1016\/j.jconrel.2026.115380_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409857","article-title":"Implantable microneedle-mediated eradication of postoperative tumor foci mitigates glioblastoma relapse","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115380_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202411869","article-title":"Self-oxygenating PROTAC microneedle for spatiotemporally-confined protein degradation and enhanced glioblastoma therapy","volume":"37","author":"Jiang","year":"2025","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0170","article-title":"Silk microneedle patch capable of on-demand multidrug delivery to the brain for glioblastoma treatment","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115380_bb0175","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jconrel.2023.04.022","article-title":"Spatiotemporal tracking of gold nanorods after intranasal administration for brain targeting","volume":"357","author":"Han","year":"2023","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb0180","doi-asserted-by":"crossref","first-page":"18327","DOI":"10.1021\/acsnano.1c07587","article-title":"A microfluidics-based scalable approach to generate extracellular vesicles with enhanced therapeutic microRNA loading for intranasal delivery to mouse glioblastomas","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb0185","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/neuonc\/noaf055","article-title":"Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy","volume":"27","author":"Lin","year":"2025","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115380_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122341","article-title":"Hyaluronan decorated layer-by-layer assembled lipid nanoparticles for miR-181a delivery in glioblastoma treatment","volume":"302","author":"Passos Gibson","year":"2023","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb0195","article-title":"CD47 knock-out using CRISPRI-Cas9 RNA lipid nanocarriers results in reduced mesenchymal glioblastoma growth in vivo","volume":"12","author":"Rouatbi","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"35","key":"10.1016\/j.jconrel.2026.115380_bb0200","doi-asserted-by":"crossref","first-page":"12773","DOI":"10.1039\/D2NR00171C","article-title":"Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy","volume":"14","author":"Sandbhor","year":"2022","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb0205","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.7150\/thno.112204","article-title":"Inorganic and hybrid nanomaterials for NIR-II fluorescence imaging-guided therapy of glioblastoma and perspectives","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb0210","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/neuonc\/noad214","article-title":"TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas","volume":"26","author":"Zheng","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb0215","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/neuonc\/noaf106","article-title":"Dual av\u03b28 integrin and PD-1 blockade overcomes TGF\u03b2-mediated B-cell suppression to enhance anti-tumor immunity","volume":"27","author":"Hou","year":"2025","journal-title":"Neuro-Oncology"},{"issue":"26","key":"10.1016\/j.jconrel.2026.115380_bb0220","doi-asserted-by":"crossref","first-page":"10904","DOI":"10.1039\/D3NR01667F","article-title":"Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy","volume":"15","author":"Wang","year":"2023","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb0230","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.jconrel.2026.115380_bb0235","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb0240","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb0245","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"28","key":"10.1016\/j.jconrel.2026.115380_bb0250","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1200\/JCO.2008.19.8721","article-title":"Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma","volume":"27","author":"Friedman","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.jconrel.2026.115380_bb0255","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMoa1707358","article-title":"Lomustine and bevacizumab in progressive glioblastoma","volume":"377","author":"Wick","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0260","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13311-022-01207-w","article-title":"RAGE inhibitors as alternatives to dexamethasone for managing cerebral edema following brain tumor surgery","volume":"19","author":"Liu","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0265","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/neuonc\/noab302","article-title":"Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors","volume":"24","author":"Knudsen","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0270","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1038\/s41467-024-46625-w","article-title":"Shared inflammatory glial cell signature after stab wound injury, revealed by spatial, temporal, and cell-type-specific profiling of the murine cerebral cortex","volume":"15","author":"Koupourtidou","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0275","doi-asserted-by":"crossref","first-page":"12145","DOI":"10.18632\/oncotarget.14553","article-title":"Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.jconrel.2026.115380_bb0280","article-title":"Mesoscale recovery of microglial and neuronal dynamics after craniotomy across wide cortex in transgenic mice","volume":"13","author":"Xiao","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0285","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1186\/s12885-021-08467-3","article-title":"Limited recurrence distance of glioblastoma under modern radiotherapy era","volume":"21","author":"Tu","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/cancers12010018","article-title":"Brain invasion along perivascular spaces by glioma cells: relationship with blood-brain barrier","volume":"12","author":"Pacioni","year":"2019","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0295","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1158\/2159-8290.CD-24-0234","article-title":"Precancerous cells initiate glioblastoma evolution and contribute to intratumoral heterogeneity","volume":"15","author":"Kim","year":"2025","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0300","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","article-title":"Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective","volume":"187","author":"Mathur","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb0305","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/neuonc\/noae011","article-title":"Cancer stem cell hypothesis 2.0 in glioblastoma: where are we now and where are we going?","volume":"26","author":"Sloan","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/nan.13012","article-title":"Characterisation of the tumour microenvironment in primary and recurrent glioblastomas","volume":"50","author":"Knudsen","year":"2024","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb0315","first-page":"665","article-title":"CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma","volume":"4","author":"van Hooren","year":"2023","journal-title":"Nat. Can."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0312764","article-title":"Single-cell transcriptomics reveals immunosuppressive microenvironment and highlights tumor-promoting macrophage cells in glioblastoma","volume":"20","author":"Cheng","year":"2025","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.jconrel.2026.115380_bb0325","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1080\/17435889.2025.2550239","article-title":"Localized treatment of glioblastoma: a review of clinical strategies and advances in drug delivery systems","volume":"20","author":"Pesce","year":"2025","journal-title":"Nanomedicine (London)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0330","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/s41467-023-37306-1","article-title":"IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1\/HER2-CREB signaling axis","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0335","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41467-025-67415-y","article-title":"Local therapeutic platform prevents postsurgical GBM recurrence by diminishing GICs and reshaping immunosuppressive microenvironment","volume":"17","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0340","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1038\/s41467-025-61999-1","article-title":"The invasion phenotypes of glioblastoma depend on plastic and reprogrammable cell states","volume":"16","author":"Doroszko","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.03.015","article-title":"Mechanisms regulating glioma invasion","volume":"362","author":"Paw","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0350","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12951-022-01479-6","article-title":"Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma","volume":"20","author":"Zhuang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"16","key":"10.1016\/j.jconrel.2026.115380_bb0355","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.7150\/thno.98163","article-title":"Preoperative PET imaging and fluorescence-guided surgery of human glioblastoma using dual-labeled antibody targeting ET(A) receptors in a preclinical mouse model: a theranostic approach","volume":"14","author":"Hautiere","year":"2024","journal-title":"Theranostics"},{"issue":"15","key":"10.1016\/j.jconrel.2026.115380_bb0360","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.7150\/thno.49787","article-title":"Irdye800cw labeled upar-targeting peptide for fluorescence-guided glioblastoma surgery: preclinical studies in orthotopic xenografts","volume":"11","author":"Kurbegovic","year":"2021","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb0365","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.7150\/thno.25599","article-title":"First-in-human study of pet and optical dual-modality image-guided surgery in glioblastoma using (68)Ga-IRDye800CW-BBN","volume":"8","author":"Li","year":"2018","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0370","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.22036","article-title":"Residual tumor cells are unique cellular targets in glioblastoma","volume":"68","author":"Glas","year":"2010","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0375","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10143-014-0593-z","article-title":"Surgical results of tumor resection using tractography-integrated navigation-guided fence-post catheter techniques and motor-evoked potentials for preservation of motor function in patients with glioblastomas near the pyramidal tracts","volume":"38","author":"Ohue","year":"2015","journal-title":"Neurosurg. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb0380","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1097\/JS9.0000000000002941","article-title":"Integrative multi-omics analysis reveal novel therapeutic targets for glioblastoma","volume":"111","author":"Li","year":"2025","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0385","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0390","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0395","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-021-00855-2","article-title":"EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma","volume":"7","author":"Gai","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0400","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41467-024-55487-1","article-title":"Endothelial-secreted endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma","volume":"16","author":"Bastola","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb0405","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma","volume":"24","author":"Yabo","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115380_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104239","article-title":"Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM","volume":"83","author":"Xiong","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0415","doi-asserted-by":"crossref","first-page":"1902071","DOI":"10.1080\/2162402X.2021.1902071","article-title":"Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas","volume":"10","author":"Yin","year":"2021","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb0420","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/neuonc\/nou113","article-title":"Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP\/isocitrate dehydrogenase 1 mutation","volume":"16","author":"Jha","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0425","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s11658-023-00514-0","article-title":"Role of N6-methyladenosine methylation in glioma: recent insights and future directions","volume":"28","author":"Li","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0430","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13046-020-01706-8","article-title":"m6A modification in rna: biogenesis, functions and roles in gliomas","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb0435","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/neuonc\/noae268","article-title":"O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner","volume":"27","author":"Qiu","year":"2025","journal-title":"Neuro-Oncology"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb0440","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.cmet.2024.09.014","article-title":"Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2","volume":"36","author":"Lv","year":"2024","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb0445","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1078-0432.CCR-23-0430","article-title":"Hypoxia-induced neuronal activity in glioma patients polarizes microglia by potentiating RNA m6A demethylation","volume":"30","author":"Guo","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0450","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/2159-8290.CD-23-1336","article-title":"Glioblastoma cortical organoids recapitulate cell-state heterogeneity and intercellular transfer","volume":"15","author":"Mangena","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.115380_bb0455","doi-asserted-by":"crossref","first-page":"217541","DOI":"10.1016\/j.canlet.2025.217541","article-title":"The development and potent antitumor efficacy of CD44\/CD133 dual-targeting IL7R\u03b1-armored CAR-T cells against glioblastoma","volume":"614","author":"Zhai","year":"2025","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb0460","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.stem.2020.04.008","article-title":"The rational development of CD133-targeting immunotherapies for glioblastoma","volume":"26","author":"Vora","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb0465","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-20-2489","article-title":"Reprogramming transcription factors Oct4 and Sox2 induce a BRD-dependent immunosuppressive transcriptome in GBM-propagating cells","volume":"81","author":"Ma","year":"2021","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb0470","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells","volume":"157","author":"Suv\u00e0","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb0475","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/neuonc\/noae040","article-title":"HIF1\u03b1\/ATF3 partake in PGK1 k191\/k192 succinylation by modulating p4ha1\/succinate signaling in glioblastoma","volume":"26","author":"Yang","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb0480","article-title":"Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma","volume":"4","author":"Pang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"19","key":"10.1016\/j.jconrel.2026.115380_bb0485","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179854","article-title":"Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment","volume":"9","author":"Rosberg","year":"2024","journal-title":"JCI Insight"},{"issue":"15","key":"10.1016\/j.jconrel.2026.115380_bb0490","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.7150\/thno.95141","article-title":"Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EPHA2","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"issue":"20","key":"10.1016\/j.jconrel.2026.115380_bb0495","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/0008-5472.CAN-14-3331","article-title":"STAT3 blockade inhibits radiation-induced malignant progression in glioma","volume":"75","author":"Lau","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0500","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-025-07617-w","article-title":"Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1\u03b1\/HIF2\u03b1 regulation","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/CBM-230486","article-title":"Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements","volume":"41","author":"Fei","year":"2024","journal-title":"Cancer Biomark."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0510","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-21-2347","article-title":"NOTCH -induced MDSC recruitment after oHSV virotherapy in CNS cancer models modulates antitumor immunotherapy","volume":"28","author":"Otani","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.jconrel.2026.115380_bb0515","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1158\/0008-5472.CAN-22-0507","article-title":"\u03b22-microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb0520","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/neuonc\/noae126","article-title":"IL-13R\u03b12\/TGF-\u03b2 bispecific CAR-T cells counter TGF-\u03b2-mediated immune suppression and potentiate anti-tumor responses in glioblastoma","volume":"26","author":"Hou","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0525","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ccell.2024.06.004","article-title":"Multi-scale signaling and tumor evolution in high-grade gliomas","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb0530","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1158\/0008-5472.CAN-04-3592","article-title":"Aberrant STAT3 signaling by Interleukin-4 in malignant glioma cells: involvement of IL-13R\u03b12","volume":"65","author":"Rahaman","year":"2005","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb0535","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0540","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115380_bb0545","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-015-0420-3","article-title":"Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF","volume":"14","author":"Fessler","year":"2015","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb0550","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1023367223575","article-title":"Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma","volume":"62","author":"Salmaggi","year":"2003","journal-title":"J. Neuro-Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb0555","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ccell.2022.08.014","article-title":"Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity","volume":"40","author":"Chryplewicz","year":"2022","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb0560","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ccell.2024.08.012","article-title":"Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence","volume":"42","author":"Watson","year":"2024","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb0565","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/neuonc\/now117","article-title":"Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model","volume":"18","author":"Okolie","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0570","doi-asserted-by":"crossref","first-page":"37437","DOI":"10.1038\/s41598-025-21272-3","article-title":"Modulation of the blood-brain barrier permeability by patient-derived glioblastoma stem cell secretome","volume":"15","author":"Sica","year":"2025","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb0575","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/acs.molpharmaceut.5c00609","article-title":"Altered abundance of barrier-related proteins in brain microvascular endothelial cells of the GL261 mouse model of glioblastoma","volume":"22","author":"Koehn","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115380_bb0580","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-2289-6_1","article-title":"Cells of the blood-brain barrier: an overview of the neurovascular unit in health and disease","volume":"2492","author":"McConnell","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.115380_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164470","article-title":"Fixed-point cleaved bioinspired nanosystem via promoting LAT1-mediated BBB penetration for spatiotemporal therapy in TMZ resistant glioblastoma","volume":"517","author":"Gu","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0590","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2015.07.013","article-title":"Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells","volume":"367","author":"Munoz","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0595","doi-asserted-by":"crossref","first-page":"28433","DOI":"10.1038\/s41598-025-13721-w","article-title":"Surface functionalized albumin nanoparticles of palbociclib with amplified brain delivery for treating brain glioblastoma","volume":"15","author":"Kurawattimath","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0600","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12951-025-03415-w","article-title":"Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood-brain barrier permeability","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb0605","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.stemcr.2022.07.010","article-title":"P450 oxidoreductase regulates barrier maturation by mediating retinoic acid metabolism in a model of the human BBB","volume":"17","author":"Zlotnik","year":"2022","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0610","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0615","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Targ."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0620","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1208\/s12249-021-01928-9","article-title":"Enhancement of therapies for glioblastoma (gbm) using nanoparticle-based delivery systems","volume":"22","author":"Wiwatchaitawee","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"15","key":"10.1016\/j.jconrel.2026.115380_bb0625","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150861","article-title":"Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing","volume":"6","author":"Xie","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0630","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Targ."},{"key":"10.1016\/j.jconrel.2026.115380_bb0635","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1038\/s41467-023-40579-1","article-title":"Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb0640","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/biom12091174","article-title":"Microglia contributes to BAF-312 effects on blood-brain barrier stability","volume":"12","author":"Spampinato","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.115380_bb0645","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12987-024-00590-0","article-title":"Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro","volume":"21","author":"Digiovanni","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0650","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.31052","article-title":"The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors","volume":"142","author":"de Gooijer","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115380_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114415","article-title":"Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment","volume":"188","author":"Pandey","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb0660","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb0665","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.22.00164","article-title":"NRG oncology\/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma","volume":"41","author":"Tsien","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"44","key":"10.1016\/j.jconrel.2026.115380_bb0670","article-title":"LncRNA-mediated TPI1 and PKM2 promote self-renewal and chemoresistance in GBM","volume":"11","author":"Yang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0675","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41467-025-56456-y","article-title":"Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma","volume":"16","author":"Zhou","year":"2025","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb0680","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41418-025-01494-8","article-title":"Lactylation-driven USP4-mediated ANXA2 stabilization and activation promotes maintenance and radioresistance of glioblastoma stem cells","volume":"32","author":"Tu","year":"2025","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb0685","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/15548627.2022.2105562","article-title":"SDC1-dependent TGM2 determines radiosensitivity in glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes","volume":"19","author":"Zheng","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.jconrel.2026.115380_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216078","article-title":"Rbbp4 regulates the expression of the mre11-rad50-nbs1 (mrn) complex and promotes DNA double-strand break repair to mediate glioblastoma chemoradiotherapy resistance","volume":"557","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115380_bb0695","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.3390\/ijms241310658","article-title":"SP1 upregulation bolsters the radioresistance of glioblastoma cells by promoting double strand breaks repair","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"734","key":"10.1016\/j.jconrel.2026.115380_bb0700","doi-asserted-by":"crossref","first-page":"eadj5962","DOI":"10.1126\/scitranslmed.adj5962","article-title":"Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to azd1390-mediated radiosensitization","volume":"16","author":"Chen","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0705","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2021.09.017","article-title":"Radioresistance and transcriptional reprograming of invasive glioblastoma cells","volume":"112","author":"Tang","year":"2021","journal-title":"Int. J .Radiat. Oncol."},{"issue":"20","key":"10.1016\/j.jconrel.2026.115380_bb0710","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1158\/0008-5472.CAN-14-3790","article-title":"Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells","volume":"75","author":"Ahmed","year":"2015","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb0715","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/biology12101295","article-title":"Cancer stem cells and glioblastoma: time for innovative biomarkers of radio-resistance?","volume":"12","author":"Pasqualetti","year":"2023","journal-title":"Biology"},{"issue":"552","key":"10.1016\/j.jconrel.2026.115380_bb0720","doi-asserted-by":"crossref","first-page":"eaaw7843","DOI":"10.1126\/scitranslmed.aaw7843","article-title":"Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance","volume":"12","author":"Akkari","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb0725","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/neuonc\/nov272","article-title":"Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization","volume":"18","author":"Stafford","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"16","key":"10.1016\/j.jconrel.2026.115380_bb0730","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1158\/0008-5472.CAN-12-0546","article-title":"Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-\u03b2","volume":"72","author":"Hardee","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0735","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-024-01763-x","article-title":"Suppression of ITPKB degradation by TRIM25 confers TMZ resistance in glioblastoma through ROS homeostasis","volume":"9","author":"Yan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0740","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40478-025-02046-4","article-title":"Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights","volume":"13","author":"Li","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"issue":"7804","key":"10.1016\/j.jconrel.2026.115380_bb0745","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","article-title":"Mechanisms and therapeutic implications of hypermutation in gliomas","volume":"580","author":"Touat","year":"2020","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.jconrel.2026.115380_bb0750","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1158\/1078-0432.CCR-08-3012","article-title":"MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance","volume":"15","author":"Yip","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0755","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.stem.2016.11.003","article-title":"Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance","volume":"20","author":"Liau","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb0760","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb0765","first-page":"1534","article-title":"A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets","volume":"3","author":"Wang","year":"2022","journal-title":"Nat. Can."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0770","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41420-020-00399-4","article-title":"CCAAT\/enhancer-binding protein delta mediates glioma stem-like cell enrichment and ATP-binding cassette transporter ABCA1 activation for temozolomide resistance in glioblastoma","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0775","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.devcel.2021.12.007","article-title":"Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy","volume":"57","author":"Xie","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jconrel.2026.115380_bb0780","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jconrel.2020.01.044","article-title":"Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3\/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes","volume":"320","author":"Chen","year":"2020","journal-title":"J. Control. Release"},{"issue":"16","key":"10.1016\/j.jconrel.2026.115380_bb0785","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2009290118","article-title":"PI3K\u03b3 inhibition suppresses microglia\/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response","volume":"118","author":"Li","year":"2021","journal-title":"P Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb0790","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/neuonc\/noaa198","article-title":"TGF-\u03b21 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT","volume":"23","author":"Nie","year":"2021","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115380_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2026.214829","article-title":"Nanoparticles for immobilization and delivery of temozolomide: functional design of carriers, advances, limitations and opportunities for glioblastoma co-therapy","volume":"184","author":"Markova","year":"2026","journal-title":"Biomater. Adv."},{"issue":"29","key":"10.1016\/j.jconrel.2026.115380_bb0800","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202504253","article-title":"Biomimetic hybrid PROTAC nanovesicles block multiple DNA repair pathways to overcome temozolomide resistance against orthotopic glioblastoma","volume":"37","author":"Xu","year":"2025","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb0805","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1021\/acsnano.1c09794","article-title":"Nano-codelivery of temozolomide and sipd-l1 to reprogram the drug-resistant and immunosuppressive microenvironment in orthotopic glioblastoma","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115380_bb0810","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jconrel.2019.08.012","article-title":"A local combination therapy to inhibit gbm recurrence","volume":"309","author":"Schwendeman","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115380_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125935","article-title":"Repurposing neurological drugs for brain cancer therapeutics: a systematic approach to identify charged molecules for affinity-based local drug delivery systems","volume":"682","author":"Sarker","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb0820","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179853","article-title":"Spatial analysis of recurrent glioblastoma reveals perivascular niche organization","volume":"9","author":"Onubogu","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.115380_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113951","article-title":"Rationally designed drug delivery systems for the local treatment of resected glioblastoma","volume":"177","author":"Bastiancich","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115380_bb0830","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.canlet.2020.01.027","article-title":"Glioblastoma precision therapy: from the bench to the clinic","volume":"475","author":"Zhou","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0835","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202511351","article-title":"Preventing glioblastoma relapse by igniting innate immunity through mitochondrial stress in the surgical cavity","volume":"38","author":"Han","year":"2026","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb0840","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200241060-00002","article-title":"Pharmacokinetics of the carmustine implant","volume":"41","author":"Fleming","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2026.115380_bb0845","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-3659(99)00098-X","article-title":"The delivery of BCNU to brain tumors","volume":"61","author":"Wang","year":"1999","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb0850","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/cancers18060907","article-title":"Limitations of Gliadel wafers and strategies for next-generation local delivery systems for glioblastoma","volume":"18","author":"Kartal","year":"2026","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb0855","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00701-005-0707-z","article-title":"Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial","volume":"148","author":"Westphal","year":"2006","journal-title":"Acta Neurochir."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0860","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12957-016-0975-5","article-title":"Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review","volume":"14","author":"Ashby","year":"2016","journal-title":"World J. Surg. Oncol."},{"issue":"45","key":"10.1016\/j.jconrel.2026.115380_bb0865","doi-asserted-by":"crossref","DOI":"10.3310\/hta11450","article-title":"The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation","volume":"11","author":"Garside","year":"2007","journal-title":"Health Technol. Assess."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb0870","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.biomaterials.2010.12.020","article-title":"Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model","volume":"32","author":"Scott","year":"2011","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb0875","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/cancers14041051","article-title":"Interstitial control-released polymer carrying a targeting small-molecule drug reduces PD-L1 and MGMT expression in recurrent high-grade gliomas with TMZ resistance","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"issue":"4 Suppl","key":"10.1016\/j.jconrel.2026.115380_bb0880","first-page":"123","article-title":"New approach in delivering chemotherapy: locoregional treatment for recurrent glioblastoma (rGBM)","volume":"22","author":"Boiardi","year":"2003","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2026.115380_bb0885","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/neuonc\/nou354","article-title":"Convection-enhanced delivery for the treatment of glioblastoma","volume":"17","author":"Vogelbaum","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb0890","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/neuonc\/nop054","article-title":"Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma","volume":"12","author":"Kunwar","year":"2010","journal-title":"Neuro-Oncology"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb0895","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1021\/jacs.4c16898","article-title":"Convection-enhanced delivery of auristatin-conjugated layer-by-layer nanoparticles for glioblastoma treatment","volume":"147","author":"Pickering","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb0900","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-21-3324","article-title":"Convection enhanced delivery of the oncolytic adenovirus Delta24-RGD in patients with recurrent GBM: a phase I clinical trial including correlative studies","volume":"28","author":"van Putten","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115380_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115657","article-title":"Convection-enhanced delivery for brain malignancies: technical parameters, formulation strategies and clinical perspectives","volume":"224","author":"Parvar","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0910","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-024-04904-y","article-title":"A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma","volume":"172","author":"Narsinh","year":"2025","journal-title":"J. Neuro-Oncol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb0915","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1470-2045(22)00599-X","article-title":"Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-Centre, single-arm, phase Ib trial","volume":"23","author":"Spinazzi","year":"2022","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0920","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1038\/s41467-019-13198-y","article-title":"Flexible, sticky, and biodegradable wireless device for drug delivery to brain tumors","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0925","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb0930","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","article-title":"Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase I trial","volume":"24","author":"Sonabend","year":"2023","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb0935","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1185\/03007990802508180","article-title":"Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience","volume":"24","author":"Sabel","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jconrel.2026.115380_bb0940","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2017.08.006","article-title":"Injectable hydrogels for sustained release of therapeutic agents","volume":"267","author":"Thambi","year":"2017","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb0945","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202400076","article-title":"Advances in injectable hydrogels based on diverse gelation methods for biomedical imaging","volume":"8","author":"Mo","year":"2024","journal-title":"Small Methods"},{"issue":"22","key":"10.1016\/j.jconrel.2026.115380_bb0950","doi-asserted-by":"crossref","first-page":"31754","DOI":"10.1021\/acsami.5c02618","article-title":"Injectable hydrogels: in-situ tissue engineering strategies for cartilage repair and regeneration","volume":"17","author":"Huang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0955","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.1038\/s41467-025-65785-x","article-title":"Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy","volume":"16","author":"Yadav","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115380_bb0960","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jconrel.2024.03.050","article-title":"Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels","volume":"369","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115380_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202307081","article-title":"Customized intranasal hydrogel delivering methylene blue ameliorates cognitive dysfunction against Alzheimer\u2019s disease","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115380_bb0970","doi-asserted-by":"crossref","first-page":"102336","DOI":"10.1016\/j.mtbio.2025.102336","article-title":"Injectable reactive oxygen and nitrogen species-scavenging hydrogels for repairing traumatic brain injury","volume":"35","author":"Zhang","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb0975","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nn.3019","article-title":"Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas","volume":"15","author":"Kauer","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"16","key":"10.1016\/j.jconrel.2026.115380_bb0980","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/1078-0432.CCR-18-3850","article-title":"Overall survival in malignant glioma is significantly prolonged by neurosurgical delivery of etoposide and temozolomide from a thermo-responsive biodegradable paste","volume":"25","author":"Smith","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115380_bb0985","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2017.08.019","article-title":"Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection","volume":"264","author":"Bastiancich","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115380_bb0990","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.actbio.2019.01.003","article-title":"In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer","volume":"86","author":"Lo","year":"2019","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb0995","first-page":"47","article-title":"White-light-induced synthesis of injectable alginate-based composite hydrogels for rapid hemostasis","volume":"10","author":"Zhang","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.jconrel.2026.115380_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120721","article-title":"Injectable nano-composite hydrogels based on hyaluronic acid-chitosan derivatives for simultaneous photothermal-chemo therapy of cancer with anti-inflammatory capacity","volume":"310","author":"Rong","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"Pt 1","key":"10.1016\/j.jconrel.2026.115380_bb1005","article-title":"Physically crosslinked chitosan\/\u03b1\u03b2-glycerophosphate hydrogels enhanced by surface-modified cyclodextrin: an efficient strategy for controlled drug release","volume":"283","author":"Tong","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115380_bb1010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jconrel.2024.07.068","article-title":"An injectable biomimetic hydrogel adapting brain tissue mechanical strength for postoperative treatment of glioblastoma without anti-tumor drugs participation","volume":"373","author":"Jia","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115380_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123128","article-title":"Injectable oxidized high-amylose starch hydrogel scaffold for macrophage-mediated glioblastoma therapy","volume":"318","author":"Ma","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115380_bb1020","article-title":"Bioprintable and injectable tio-loaded hydrogels for photothermal therapy of glioma","volume":"32","author":"Tian","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb1025","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/brain\/awab466","article-title":"A daily temperature rhythm in the human brain predicts survival after brain injury","volume":"145","author":"Rzechorzek","year":"2022","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb1030","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1021\/acsnano.2c10094","article-title":"Penetrative and sustained drug delivery using injectable hydrogel nanocomposites for postsurgical brain tumor treatment","volume":"17","author":"Kang","year":"2023","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb1035","doi-asserted-by":"crossref","first-page":"eadx9671","DOI":"10.1126\/sciadv.adx9671","article-title":"STING stimulation via supramolecular prodrug hydrogel boosts innate-adaptive immune cross-talk to prevent glioblastoma recurrence","volume":"12","author":"Shang","year":"2026","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb1040","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab56f9","article-title":"Three-dimensional printing of chemically crosslinked gelatin hydrogels for adipose tissue engineering","volume":"12","author":"Contessi Negrini","year":"2020","journal-title":"Biofabrication"},{"issue":"30","key":"10.1016\/j.jconrel.2026.115380_bb1045","doi-asserted-by":"crossref","first-page":"2401383","DOI":"10.1002\/adfm.202401383","article-title":"Assembled embedded 3D hydrogel system for asynchronous drug delivery to inhibit postoperative recurrence of malignant glioma and promote neurological recovery","volume":"34","author":"Hu","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115380_bb1050","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300671","article-title":"Development of a synthetic, injectable hydrogel to capture residual glioblastoma and glioblastoma stem-like cells with CXCL12-mediated chemotaxis","volume":"12","author":"Khan","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115380_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164175","article-title":"Hydrogel-based implantable system for local delivery of temozolomide in postsurgical brain cancer therapy","volume":"516","author":"Krajcer","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb1060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/gels11070483","article-title":"Advances in nanohybrid hydrogels for wound healing: from functional mechanisms to translational prospects","volume":"11","author":"Mo","year":"2025","journal-title":"Gels"},{"issue":"34","key":"10.1016\/j.jconrel.2026.115380_bb1065","doi-asserted-by":"crossref","first-page":"22780","DOI":"10.1021\/acsnano.4c06888","article-title":"Hybrid nanoparticle-hydrogel systems for drug delivery depots and other biomedical applications","volume":"18","author":"Choi","year":"2024","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.jconrel.2026.115380_bb1070","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311109","article-title":"Intracavitary spraying of nanoregulator-encased hydrogel modulates cholesterol metabolism of glioma-supportive macrophage for postoperative glioblastoma immunotherapy","volume":"36","author":"Dong","year":"2024","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.jconrel.2026.115380_bb1075","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1021\/acsnano.4c02425","article-title":"In situ sprayed exosome-cross-linked gel as artificial lymph nodes for postoperative glioblastoma immunotherapy","volume":"18","author":"Bao","year":"2024","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb1080","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41416-024-02878-2","article-title":"Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma","volume":"131","author":"Serra","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115380_bb1085","article-title":"Multi-material electrospinning: from methods to biomedical applications","volume":"21","author":"Xing","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"28","key":"10.1016\/j.jconrel.2026.115380_bb1090","article-title":"Electrospinning and nanofiber technology: fundamentals, innovations, and applications","volume":"37","author":"Cho","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115380_bb1095","article-title":"Intelligent electrospinning nanofibrous membranes for monitoring and promotion of the wound healing","volume":"26","author":"Qu","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb1100","doi-asserted-by":"crossref","first-page":"2413518","DOI":"10.1002\/adfm.202413518","article-title":"Engineering of nanofibers embedded with targeted nanoparticles breaks redox levers for glioblastoma therapy","volume":"35","author":"Ma","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1105","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1038\/s41467-026-75065-x","article-title":"Time-staggered chemo-immunotherapy via engineered nanofiber resists postoperative dynamic immunosuppression in glioblastoma","volume":"17","author":"Song","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s42765-022-00210-2","article-title":"NIR-II-triggered composite nanofibers to simultaneously achieve intracranial hemostasis, killing superbug and residual cancer cells in brain tumor resection surgery","volume":"5","author":"Yang","year":"2023","journal-title":"Adv. Fiber Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb1115","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1039\/D3NJ00534H","article-title":"Locally implantable nanofibre meshes by sustained release of temozolomide for combined thermo-chemotherapy to treat glioblastoma","volume":"47","author":"Oe","year":"2023","journal-title":"New J. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb1120","first-page":"963","article-title":"Advanced fabrication for electrospun three-dimensional nanofiber aerogels and scaffolds","volume":"5","author":"Chen","year":"2020","journal-title":"Bioact. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb1125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/polym16081029","article-title":"The impacts of the sterilization method and the electrospinning conditions of nanofibrous biodegradable layers on their degradation and hemocompatibility behavior","volume":"16","author":"Havlickova","year":"2024","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2026.115380_bb1130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jconrel.2020.07.038","article-title":"Progress in the design and development of \u201cfast-dissolving\u201d electrospun nanofibers based drug delivery systems-a systematic review","volume":"326","author":"Balusamy","year":"2020","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.jconrel.2026.115380_bb1135","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202501994","article-title":"3D bioprinting models for glioblastoma: from scaffold design to therapeutic application","volume":"37","author":"Branco","year":"2025","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb1140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/pharmaceutics13040471","article-title":"Three-dimensional printing of curcumin-loaded biodegradable and flexible scaffold for intracranial therapy of glioblastoma multiforme","volume":"13","author":"Li","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb1145","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41565-021-00879-3","article-title":"Conformable hierarchically engineered polymeric micromeshes enabling combinatorial therapies in brain tumours","volume":"16","author":"Di Mascolo","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb1150","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202406178","article-title":"A self-cascading catalytic therapy and antigen capture scaffold-mediated t cells augments for postoperative brain immunotherapy","volume":"21","author":"Yalamandala","year":"2024","journal-title":"Small"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115380_bb1155","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/neuonc\/noad133","article-title":"The surgical management of diffuse gliomas: current state of neurosurgical management and future directions","volume":"25","author":"Young","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115380_bb1160","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.addr.2021.04.019","article-title":"Emerging 3D printing technologies for drug delivery devices: current status and future perspective","volume":"174","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115380_bb1165","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.addr.2021.05.003","article-title":"Translating 3D printed pharmaceuticals: from hype to real-world clinical applications","volume":"174","author":"Seoane-Via\u00f1o","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115380_bb1170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jconrel.2022.04.043","article-title":"Dissolvable polymer microneedles for drug delivery and diagnostics","volume":"347","author":"Ali","year":"2022","journal-title":"J. Control. Release"},{"issue":"33","key":"10.1016\/j.jconrel.2026.115380_bb1175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202420630","article-title":"Intranasal and intravenous sequential administration of survivin peptide-CPG nanovaccines elicits potent immunity toward glioblastoma","volume":"37","author":"Shi","year":"2025","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1180","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1038\/s41467-026-76103-4","article-title":"Low-intensity pulsed ultrasound-mediated nose-to-brain co-delivery of \u03b2-blockers and APD-l1 enhances glioblastoma immunotherapy","volume":"17","author":"Dong","year":"2026","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb1185","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jps.21604","article-title":"Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system","volume":"98","author":"Dhuria","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb1190","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.xphs.2024.05.003","article-title":"Left-right difference in brain pharmacokinetics following nasal administration via one-site nostrils","volume":"113","author":"Tanaka","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115380_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104756","article-title":"Nose-to-brain drug delivery: challenges and progress towards brain targeting in the treatment of neurological disorders","volume":"86","author":"Raghav","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1200","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/acsami.4c16837","article-title":"Nose-to-brain delivery of biomimetic nanoparticles for glioblastoma targeted therapy","volume":"17","author":"Ferreira","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115380_bb1205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jconrel.2023.01.070","article-title":"Nasal administration of a temozolomide-loaded thermoresponsive nanoemulsion reduces tumor growth in a preclinical glioblastoma model","volume":"355","author":"Michels","year":"2023","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115380_bb1210","doi-asserted-by":"crossref","first-page":"CASE22215","DOI":"10.3171\/CASE22215","article-title":"Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case","volume":"4","author":"Sch\u00f6nthal","year":"2022","journal-title":"J. Neurosurg. Case Lessons"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1215","doi-asserted-by":"crossref","first-page":"vdab005","DOI":"10.1093\/noajnl\/vdab005","article-title":"Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma","volume":"3","author":"Sch\u00f6nthal","year":"2021","journal-title":"Neuro Oncol. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb1220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/17425247.2025.2578384","article-title":"Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part I: receptor-mediated nose-to-brain delivery approaches for glioblastoma","volume":"23","author":"Qamar","year":"2026","journal-title":"Expert Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb1225","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2174\/1389200217666160406120509","article-title":"Drug-metabolizing enzymes and efflux transporters in nasal epithelium: influence on the bioavailability of intranasally administered drugs","volume":"17","author":"Oliveira","year":"2016","journal-title":"Curr. Drug Metab."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb1230","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s13346-020-00747-y","article-title":"Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management","volume":"10","author":"Upadhaya","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115380_bb1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114326","article-title":"Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy","volume":"200","author":"Ramalho","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb1240","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1245","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41467-024-45254-7","article-title":"Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery","volume":"15","author":"Miao","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1250","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115380_bb1255","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.tips.2025.08.006","article-title":"Beyond the blood-brain barrier: the fate of transcytosed therapeutics","volume":"46","author":"Baghirov","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb1260","doi-asserted-by":"crossref","first-page":"eadr1481","DOI":"10.1126\/sciadv.adr1481","article-title":"Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM","volume":"11","author":"Jimenez-Macias","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115380_bb1265","article-title":"Rational design of siRNA-based delivery systems for effective treatment of brain diseases","volume":"2","author":"Lu","year":"2024","journal-title":"Pharmaceut. Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115380_bb1270","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jconrel.2023.01.072","article-title":"Modulation of blood-brain tumor barrier for delivery of magnetic hyperthermia to brain cancer","volume":"355","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.jconrel.2026.115380_bb1275","article-title":"Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1280","doi-asserted-by":"crossref","first-page":"2000124","DOI":"10.1002\/adtp.202000124","article-title":"Targeting glioblastoma: advances in drug delivery and novel therapeutic approaches","volume":"4","author":"Yeini","year":"2021","journal-title":"Adv. Ther."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb1285","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/neuonc\/noaf162","article-title":"Lipid nanoparticle formulation for gene editing and RNA-based therapies for glioblastoma","volume":"27","author":"Zhang","year":"2025","journal-title":"Neuro-Oncology"},{"issue":"30","key":"10.1016\/j.jconrel.2026.115380_bb1290","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202101701","article-title":"Sphingosine 1-phosphate liposomes for targeted nitric oxide delivery to mediate anticancer effects against brain glioma tumors","volume":"33","author":"Liu","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115380_bb1295","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2022.03.019","article-title":"Enhanced BBB and BBTB penetration and improved anti-glioma behavior of bortezomib through dual-targeting nanostructured lipid carriers","volume":"345","author":"Farshbaf","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115380_bb1300","doi-asserted-by":"crossref","first-page":"1641752","DOI":"10.3389\/fonc.2025.1641752","article-title":"Chemotherapeutic nanoparticles for glioblastoma","volume":"15","author":"Messina","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115380_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122479","article-title":"Gint4.T-siHDGF chimera-capped mesoporous silica nanoparticles encapsulating temozolomide for synergistic glioblastoma therapy","volume":"306","author":"Fei","year":"2024","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.jconrel.2026.115380_bb1310","doi-asserted-by":"crossref","first-page":"21722","DOI":"10.1021\/acsami.4c04289","article-title":"Overcoming the blood-brain tumor barrier with docetaxel-loaded mesoporous silica nanoparticles for treatment of temozolomide-resistant glioblastoma","volume":"16","author":"Hsu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115380_bb1315","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101619","article-title":"A biodegradable nanocapsule for through-skull NIR-II fluorescence imaging\/magnetic resonance imaging and selectively enhanced radio-chemotherapy for orthotopic glioma","volume":"46","author":"Yin","year":"2022","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb1320","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.7150\/thno.80632","article-title":"Engineered apoptotic bodies hitchhiking across the blood-brain barrier achieved a combined photothermal-chemotherapeutic effect against glioma","volume":"13","author":"Liu","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115380_bb1325","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jconrel.2022.07.023","article-title":"Polymeric nanoparticles for drug delivery in glioblastoma: state of the art and future perspectives","volume":"349","author":"Madani","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115380_bb1330","doi-asserted-by":"crossref","first-page":"1519479","DOI":"10.3389\/fphar.2024.1519479","article-title":"Applications of polymeric nanoparticles in drug delivery for glioblastoma","volume":"15","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb1335","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/jbm.b.33648","article-title":"Polymer degradation and drug delivery in plga-based drug-polymer applications: a review of experiments and theories","volume":"105","author":"Xu","year":"2016","journal-title":"J. Biomed. Mater. Res. B"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb1340","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.7150\/thno.38147","article-title":"Nanocarrier-based drug combination therapy for glioblastoma","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1158\/1078-0432.CCR-20-2156","article-title":"Spatiotemporal heterogeneity in multiparametric physiologic mri is associated with patient outcomes in idh-wildtype glioblastoma","volume":"27","author":"Park","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.jconrel.2026.115380_bb1350","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118697119","article-title":"A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles","volume":"119","author":"Straehla","year":"2022","journal-title":"P Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115380_bb1355","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119666","article-title":"An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy","volume":"230","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb1360","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202504381","article-title":"Semiconducting polymer nanotransducers reinvigorate antitumor immunity through amplifying radio\/chemodynamic therapy in orthotopic glioma","volume":"15","author":"Zhu","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115380_bb1365","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jconrel.2024.09.037","article-title":"New avenues for cancer immunotherapy: cell-mediated drug delivery systems","volume":"375","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115380_bb1370","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1007\/s13346-024-01591-0","article-title":"Cell-mediated nanoparticle delivery systems: towards precision nanomedicine","volume":"14","author":"Cheng","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115380_bb1375","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.7150\/thno.99257","article-title":"Theoretical basis, state and challenges of living cell-based drug delivery systems","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115380_bb1380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","article-title":"Neutrophils as emerging therapeutic targets","volume":"19","author":"N\u00e9meth","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115380_bb1385","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb1390","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1395","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1038\/s41467-018-07250-6","article-title":"MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma","volume":"9","author":"Wu","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb1400","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41417-024-00775-7","article-title":"Mesenchymal stem cells as therapeutic vehicles for glioma","volume":"31","author":"Oishi","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb1405","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/biomedicines10050986","article-title":"To explore the stem cells homing to GBM: the rise to the occasion","volume":"10","author":"Tsibulnikov","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1410","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13287-018-1049-0","article-title":"Tropism of mesenchymal stem cell toward CD133+ stem cell of glioblastoma in vitro and promote tumor proliferation in vivo","volume":"9","author":"Pavon","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1415","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3171\/2016.9.JNS16278","article-title":"Ionizing radiation augments glioma tropism of mesenchymal stem cells[J]","volume":"128","author":"Thomas","year":"2017","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115380_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2025.102041","article-title":"Bridging process diversity in cell therapies toward standardization of manufacturing workflows","volume":"28","author":"Costa","year":"2026","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115380_bb1425","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ymthe.2024.11.035","article-title":"Managing allorejection in off-the-shelf car-engineered cell therapies","volume":"33","author":"Li","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115380_bb1430","doi-asserted-by":"crossref","first-page":"1190016","DOI":"10.3389\/fmed.2023.1190016","article-title":"Potency testing of cell and gene therapy products","volume":"10","author":"Salmikangas","year":"2023","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115380_bb1435","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"52","key":"10.1016\/j.jconrel.2026.115380_bb1440","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201054","article-title":"Extracellular-vesicle-based drug delivery systems for enhanced antitumor therapies through modulating the cancer-immunity cycle","volume":"34","author":"Yong","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115380_bb1445","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216093","article-title":"Tumor-targeted exosomes for delivery of anticancer drugs","volume":"558","author":"Raguraman","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.115380_bb1450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb1455","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ymthe.2019.05.016","article-title":"Malignant glioma therapy by vaccination with irradiated C6 cell-derived microvesicles promotes an antitumoral immune response","volume":"27","author":"Pineda","year":"2019","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1460","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13578-022-00786-7","article-title":"Heterogeneity of mesenchymal stem cell-derived extracellular vesicles is highly impacted by the tissue\/cell source and culture conditions","volume":"12","author":"Almeria","year":"2022","journal-title":"Cell Biosci."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115380_bb1465","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12266","article-title":"Comparative analysis of tangential flow filtration and ultracentrifugation, both combined with subsequent size exclusion chromatography, for the isolation of small extracellular vesicles","volume":"11","author":"Visan","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb1470","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115380_bb1475","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70332","article-title":"Regulatory challenges and opportunities for cell-derived extracellular vesicles in pharmaceutical development: a European and global perspective","volume":"15","author":"Limongi","year":"2026","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115380_bb1480","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13287-024-03708-1","article-title":"Manufacturing, quality control, and GLP-grade preclinical study of nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles","volume":"15","author":"Wang","year":"2024","journal-title":"Stem Cell Res. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:47:53Z","timestamp":1793440073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":296,"alternative-id":["S0168365926007844"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115380","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative glioblastoma management: from relapse mechanisms and clinical interventions to emerging drug delivery strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115380"}}